← FDA ENFORCEMENT
D-0577-2026Class II
Guardian Drug Co. Inc.
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
Guardian Drug Co. Inc.
Product type
Drug
Status
Ongoing
Report date
2026-06-10
Distribution
U.S.A. Nationwide
Firm state
NJ
Initiated by
Voluntary: Firm initiated
Reason for recall
Presence of foreign substance: small metallic particles in chewable tablets.
Product description
EQUALINE ultra strength, antacid tablets, calcium carbonate 1000mg, 72 chewable tablets, DISTRIBUTED BY SUPERVALU INC.,EDEN PRARIE, MN 55344 USA, NDC 41163-171-68.
Code / lot info
Lot #: 1716089, expires: JAN- 2029.
Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →